PUBLISHER: Lucintel | PRODUCT CODE: 1386507
PUBLISHER: Lucintel | PRODUCT CODE: 1386507
Viral Vector Manufacturing Trends and Forecast
The future of the global viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets. The global viral vector manufacturing market is expected to reach an estimated $3.0 billion by 2030 with a CAGR of 18.7% from 2024 to 2030. The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing, and technological advancements in viral vector manufacturing.
A more than 150-page report is developed to help in your business decisions.
Viral Vector Manufacturing by Segment
The study includes a forecast for the global viral vector manufacturing by type, workflow, application, end use, and region.
Viral Vector Manufacturing Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Viral Vector Manufacturing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
Viral Vector Manufacturing Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Viral Vector Manufacturing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Viral Vector Manufacturing Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Viral Vector Manufacturing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies viral vector manufacturing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the viral vector manufacturing companies profiled in this report include-
Viral Vector Manufacturing Market Insights
Lucintel forecasts that cell and gene therapy is expected to witness highest growth over the forecast period due to growing demand for cell and gene therapies for the treatment of a wide range of diseases, including cancer, rare diseases, and genetic disorders.
Within this market, pharmaceutical and biopharmaceutical will remain the largest segment due to the fact that these pharmaceutical and biopharmaceutical companies companies are developing and commercializing viral vector-based therapies for a wide range of diseases, including cancer, rare diseases, and infectious diseases.
North America is expected to witness highest growth over the forecast period due to increasing demand for viral vector-based therapies from the pharmaceutical and biotechnology industries in the region.
Features of the Global Viral Vector Manufacturing Market
Market Size Estimates: Viral vector manufacturing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Viral vector manufacturing market size by various segments, such as by type, workflow, application, end use, and region in terms of value ($B).
Regional Analysis: Viral vector manufacturing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, workflows, applications, end uses, and regions for the viral vector manufacturing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the viral vector manufacturing market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the viral vector manufacturing market size?
Answer: The global viral vector manufacturing market is expected to reach an estimated $3.0 billion by 2030.
Q.2 What is the growth forecast for viral vector manufacturing market?
Answer: The global viral vector manufacturing market is expected to grow with a CAGR of 18.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the viral vector manufacturing market?
Answer: The major drivers for this market are increasing demand for viral vector-based therapies, growing investment in viral vector manufacturing and technological advancements in viral vector manufacturing.
Q4. What are the major segments for viral vector manufacturing market?
Answer: The future of the viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institutes markets.
Q5. Who are the key viral vector manufacturing market companies?
Answer: Some of the key viral vector manufacturing companies are as follows:
Q6. Which viral vector manufacturing market segment will be the largest in future?
Answer: Lucintel forecasts that cell and gene therapy is expected to witness highest growth over the forecast period due to growing demand for cell and gene therapies for the treatment of a wide range of diseases, including cancer, rare diseases, and genetic disorders.
Q7. In viral vector manufacturing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing demand for viral vector-based therapies from the pharmaceutical and biotechnology industries in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.